THURSDAY, MARCH 24 - PHARMACOLOGY PRECONFERENCE AND GENERAL SESSIONS | |
7:30 AM PT | Product Theater Clincial Insights in CAD and/or PAD: Reducing the Risk of Major Cardiovascular Events Sponsored by Janssen |
8:45 AM PT | Welcome to Pharmacology Preconference |
9:00 AM PT | Prevention and Treatment of COVID-19: A Review of the Current Data Ty Gluckman MD, FACC, FAHA |
9:50 AM PT | Break |
10:05 AM PT | Contraception, Hormone Replacement Therapy and Cardiovascular Disease Pamela Morris, MD, FACC, FAHA, FASPC, FNLA |
10:55 AM PT | Supplement Use in Cardiovascular Patients: What You Need to Know Rhonda Cooper-Dehoff, PharmD |
11:45 AM PT | Break |
12:00 PM PT | Product Theater Recurrent Pericarditis Sponsored by Kiniksa |
1:00 PM PT | Heart Failure: Evidenced-based Pharmacologic Therapies Kimberly Cuomo, RN, MSN, CRNP, CHFN |
1:50 PM PT | Impacts of SGLT2s and GLP1s on CVD, Diabetes, and Renal Function Eryn Bryant, MSN, NP-C and Sun Kim, MD, MS |
2:40 PM PT | Break |
3:30 PM PT | Welcome to General Sessions |
3:45 PM PT | Opening and Honorary Fellow Keynote: Assessing Cardiovascular Risk: Where are the Data Now and Where Do We Go From Here? Donald Lloyd-Jones, MD, ScM, FACC, FAHA |
4:45 PM PT | Spectrum of CKD and the Impact on Overall Cardiovascular Health Rajesh Mahandas, MD, MPH |
5:30 PM CT | Conclude Day 1 |
FRIDAY, MARCH 25 - GENERAL SESSIONS | |
7:30 AM PT | Welcome Poster Winners Announced |
7:45 AM PT | Complex Cases in Lipid Management: Treating LDL and Beyond Susan Halli-Demeter DNP, CNP, FNP-BC |
8:35 AM PT | Break |
8:50 AM PT | Resistant Hypertension: Who is at risk? Detection, Evaluation and Treatment Vivek Bhalla, MD |
9:40 AM PT | COVID-19 Long-Haulers: The search for answers Amanda K. Verma, MD, FACC |
10:15 AM PT | Oral Abstract Presentations Original Research: Relationships Between Physical Activity Metrics of Intensity and Diabetes Elizabeth Moxley, PhD, BS, RN Innovative Project: Titration Guidelines as a Tool to Decrease Medication Errors Christina Trupia, RN, BSN Graduate Capstone: Heart Failure Education: Evaluating Telemetry Nurses’ Knowledge and Confidence Caroline Khoury DiBiagio, DNP, AGACNP-BC |
10:45 AM PT | Virtual Networking Event via Zoom |
11:30 AM PT | Management of Atrial Fibrillation, from A to Z Bill Miles, MD, FACC |
12:15 PM PT | Product Theater Add on Efficacy. Oral, Nonstatin Therapies for Lowering LDL-C Sponsored by: Esperion |
1:15 PM PT | Break |
2:15 PM PT | Maternal Mortality, Cardiovascular Disease and Prevention Erin Ferranti, PhD, MPH, RN, FAHA Abha Khandelwal, MD |
3:00 AM PT | Break |
3:10 PM PT | Break Out Session |
Essential Skills for Today's Nurse Leaders: Making an Impact with Social Media Lynne Braun, RN, PhD | |
4:10 PM PT | Conclude Day 2 |
SATURDAY, MARCH 26 - GENERAL SESSIONS | |
7:25 AM PT | Welcome |
7:30 AM PT | CVD and Oncology Links 2021-2022: PCNA and International Cardio-Oncology Society (Non-CE) Anecita Fadol, PhD, APRN, FAANP, FAAN Jacqueline Vo, PhD, RN, MPH Supported by Non-CE funding from Bristol-Myers Squibb – Pfizer Alliance |
8:30 AM PT | Awards Ceremony |
8:50 AM PT | Cardiovascular Health and CVD Risk in LGBTQ+ Populations Billy Caceres, PhD, RN, FAHA, FAAN |
9:50 AM PT | Beverage Break |
10:10 AM PT | Precision Medicine and Genetics: Implications for CVD Prevention and Management Carolyn Yung Ho, MD |
10:50 AM PT | Closing Keynote: Posttraumatic Growth: Renewing your health and well-being following the COVID-19 pandemic Tim Cunningham, RN, DrPH, FAAN |
11:55 AM PT | Closing |